This event has ended. Visit the official site or create your own event on Sched.
Learn the latest cancer care information to benefit your patients and earn up to 30 CNE contact hours! Register now at congress.ons.org.
Back To Schedule
Thursday, April 28 • 6:00am - 7:30am
5-Fluorouracil and Capecitabine Emergencies - Recognition and Treatment of Early Onset Severe Toxicity and Overdose

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Learning Objectives:
—- Review the mechanism of action of 5-fluorouracil, and
become familiar with the cytotoxic metabolites that
cause early-onset toxicity.
—- Understand the causes of 5-fluorouracil overdose, and
the “red flags” of unusual, early-onset severe toxicity.
— - Describe how uridine triacetate provides an emergency
treatment for adult and pediatric patients following a
fluorouracil or capecitabine overdose and who exhibit
early-onset, severe or life threatening toxicity.
-— Provide information on the administration of uridine
triacetate oral granules and its limitations of use.

This Non-CNE Symposium is co-sponsored by BTG International Inc. and Wellstat Therapeutics.

Symposia events require separate registration. Please click here to register for this event. 

Thursday April 28, 2016 6:00am - 7:30am CDT
Hemisfair Ballroom